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While fatty acids (FAs) released by white adipose
tissue (WAT) provide energy for other organs, lipol-
ysis is also critical in brown adipose tissue (BAT),
generating FAs for oxidation and UCP-1 activation
for thermogenesis. Here we show that adipose-
specific ablation of desnutrin/ATGL in mice converts
BAT to aWAT-like tissue. Thesemice exhibit severely
impaired thermogenesis with increased expression
of WAT-enriched genes but decreased BAT genes,
including UCP-1 with lower PPARa binding to its
promoter, revealing the requirement of desnutrin-
catalyzed lipolysis for maintaining a BAT phenotype.
We also show that desnutrin is phosphorylated by
AMPK at S406, increasing TAG hydrolase activity,
and provide evidence for increased lipolysis by
AMPK phosphorylation of desnutrin in adipocytes
and in vivo. Despite adiposity and impairedBAT func-
tion, desnutrin-ASKO mice have improved hepatic
insulin sensitivity with lower DAG levels. Overall, des-
nutrin is phosphorylated/activated by AMPK to
increase lipolysis and brings FA oxidation and UCP-
1 induction for thermogenesis.
INTRODUCTION
Adipose tissue plays a critical role in controlling energy balance.
As the primary fuel reserve in mammals, white adipose tissue
(WAT) has the unique function of storing triacylglycerol (TAG)
for hydrolysis (lipolysis) to provide fatty acids (FAs) for other
organs during times of energy shortage (Ahmadian et al.,
2009a). Brown adipose tissue (BAT), on the other hand, is
specialized in thermogenesis, using FAs generated by lipolysis
for activation of UCP-1 and for mitochondrial b-oxidation
(Cannon and Nedergaard, 2004). These two adipose tissues
canbedistinguished fromeachother based on theirmorphology,
gene expression profile, and characteristic biochemical func-Ctions (Frontini and Cinti, 2010). Under certain conditions, such
as chronic cold exposure, not only is the thermogenic capacity
of BAT increased, but WAT can also be converted to a BAT-like
tissue (Frontini and Cinti, 2010). In contrast, while BAT is abun-
dant in newborns, the majority is transformed to WAT in adult
humans. Yet how these conversions between BAT and WAT
occur is not well understood (Frontini and Cinti, 2010).
It is clear that lipolysis is a critical metabolic process in both
WAT and BAT. Lipolysis occurs in three stages, with different
enzymes acting at each step: TAG is hydrolyzed to form diacyl-
glycerol (DAG), catalyzed by desnutrin/ATGL/iPLA2z (gene
name: PNPLA2, TTS2.2), which we and others identified as the
major TAG hydrolase in adipose tissue, but which is also ex-
pressed in other tissues (Villena et al., 2004a; Jenkins et al.,
2004; Zimmermann et al., 2004). DAG is then hydrolyzed by
hormone-sensitive lipase (HSL) tomonoacylglycerol and, subse-
quently, glycerol, with a FA released at each stage (Duncan et al.,
2007). Regulation of lipolysis by catecholamine stimulation of
Gas-coupled b-adrenergic receptors, resulting in PKA phos-
phorylation of HSL and perilipin, is well characterized (Ahmadian
et al., 2009a). Yet how desnutrin is regulated by phosphorylation
is not known. Mass spectrometry analysis identified two serine
residues in murine desnutrin that are phosphorylated (Kim
et al., 2006). However, PKA does not appear to phosphorylate
desnutrin (Zimmermann et al., 2004). Another kinase that plays
a critical role in maintaining energy balance is AMP-activated
protein kinase (AMPK), a serine/threonine kinase that is acti-
vated during a low-energy state (Lage et al., 2008). However,
its role in regulating lipolysis in adipose tissue has been contro-
versial, and whether it phosphorylates mammalian desnutrin is
unknown (Daval et al., 2005; Yin et al., 2003).
We previously found that adipose overexpression of desnutrin
in mice increases lipolysis, FA oxidation within adipose tissue,
and thermogenesis, resulting in higher energy expenditure and
resistance to obesity (Ahmadian et al., 2009b). Global ablation
of desnutrin/ATGL in mice results in massive TAG accumulation
in multiple organs, causing premature death (Haemmerle et al.,
2006). Thus, adipose-specific ablation of desnutrin is required
to determine its adipose-autonomous effects on BAT and WAT
and its role in obesity. Here we report that adipose-specific abla-
tion of desnutrin (desnutrin-ASKO) not only manifests in obesityell Metabolism 13, 739–748, June 8, 2011 ª2011 Elsevier Inc. 739
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mice exhibit impaired thermogenesis with decreased expression
of UCP-1, with lower PPARa binding to its promoter, revealing
the requirement of desnutrin-catalyzed lipolysis in the mainte-
nance of a BAT phenotype. We also show that desnutrin is
phosphorylated at S406 by AMPK, to increase its TAG hydrolase
activity, and provide evidence for regulation of lipolysis by AMPK
phosphorylation of desnutrin in both cultured adipocytes and
in vivo in mice. We conclude that desnutrin is phosphorylated
by AMPK to increase lipolysis and that desnutrin-catalyzed lipol-
ysis brings FA oxidation and UCP-1 induction for thermogenesis.
RESULTS
Diet-Induced Obesity in Desnutrin-ASKO Mice Results
from Blunted Lipolysis and Impaired Thermogenesis
We generated adipose-specific desnutrin knockout mice (des-
nutrin-ASKO mice) using the Flp-Cre strategy, and these mice
were compared to control, flox/flox littermates for all experi-
ments (Figures 1A and S1A–S1C). Desnutrin protein in WAT
and BAT was easily detected in control, flox/flox mice but was
barely detectable in desnutrin-ASKO mice (Figure 1B, upper).
In other organs, such as the heart and liver, desnutrin protein
levels were unchanged compared to control mice (Figure 1B,
middle). RT-qPCR also detected minimal changes in desnutrin
expression in macrophages, compared to the drastic decrease
in BAT (Figure 1B, lower).
By 5 weeks of age, desnutrin-ASKO mice on a HFD showed
a trend toward a higher rate of weight gain than flox/flox litter-
mates, reaching statistical significancebetween12and14weeks
of age (Figures 1C and S1D, right). Increased weight gain and fat
pad weights were also observed in desnutrin-ASKO mice on
chow diet, albeit to a lesser extent (Figures S1D, left, and S1E).
However, desnutrin-ASKO mice consumed the same amount
of food as flox/flox littermates (Figure 1E, inset). Liver, kidney,
and heart weights were similar and therefore could not account
for the higher body weights in desnutrin-ASKO mice (Figure 1F).
On the other hand, after 20 weeks on a HFD, gonadal, inguinal,
and renal WAT depot weights were 1.4-, 2.0-, and 1.9-fold
higher, respectively, in desnutrin-ASKO mice compared to
control mice (Figure 1E). BAT was even more affected than
WAT, with weights 4.9-fold higher, and resembling WAT in terms
of its pale color (Figures 1D and 1E). Histological analysis
revealed a greater frequency of larger adipocytes in gonadal
fat pads from desnutrin-ASKOmice, indicating increased adipo-
cyte size (Figure 1G, left). Brown adipocyte size was also mark-
edly increased in desnutrin-ASKO mice (Figure 1G, right).
Expression levels of early as well as late markers of adipo-
cyte differentiation in WAT of desnutrin-ASKO mice were not
changed, indicatingnormaladipocytedifferentiation (FigureS1F).
Glycerol release was drastically decreased in WAT of desnutrin-
ASKO mice compared to control mice under both basal and
isoproterenol-stimulated conditions (Figure 2A, left). Although
not significantly different under basal conditions in WAT, FA
release was decreased by 22% after 2 hr and 41% after 4 hr in
WAT of desnutrin-ASKO mice under isoproterenol-stimulated
conditions (Figure 2A, right). In isolated adipocytes, we detected
decrease in FA release under both basal and stimulated condi-
tions (Figure 2B). Lipolysis was also severely blunted in BAT of740 Cell Metabolism 13, 739–748, June 8, 2011 ª2011 Elsevier Inc.desnutrin-ASKO mice, being decreased by 60% under basal
conditions (Figure 2C). Next, using a heavy water labeling tech-
nique, we measured in vivo TAG turnover and de novo palmitate
turnover in WAT and BAT. While TAG turnover was 24% after
6 days in WAT of control mice, it was only 7% in desnutrin-
ASKO mice (Figure 2D, left). Surprisingly, in BAT of control
mice, TAG turnover was markedly higher than that in WAT, with
a 77% turnover rate after 6 days (Figure 2D, left). However, in
BAT of desnutrin-ASKO mice, it was only 29%, which is similar
to levels observed inWATof controlmice (Figure 2D, left). Consis-
tent with these findings, de novo palmitate turnover was 8% and
52% inWAT and BAT of control mice, respectively, compared to
3% and 9% in desnutrin-ASKO mice (Figure 2D, right).
We next subjected desnutrin-ASKO mice and flox/flox litter-
mates to cold exposure in the fasted state. While control mice
were able to maintain body temperature well into 5 hr at 4C,
desnutrin-ASKO mice quickly reached life-threatening hypo-
thermia after just 90 min (Figure 2E). Cold exposure increased
TAG hydrolase activity in BAT of control mice by 2.3-fold, but
only 1.4-fold in desnutrin-ASKOmice, indicating the requirement
of desnutrin for cold-induced increase in TAG hydrolase activity
(Figure 2F). Notably, we did not observe any changes in desnu-
trin protein levels in BAT after cold exposure, suggesting that
desnutrin activity may be regulated in BAT by posttranslational
modification (Figure 2F, inset). There was no change in ambula-
tory activity (data not shown). However, total oxygen consump-
tion was decreased in desnutrin-ASKO mice compared to flox/
flox littermates (Figure 2G). In response to the b3-agonist,
CL316243, flox/flox mice exhibited a drastic increase in their
metabolic rate, as indicated by oxygen consumption, whereas
desnutrin-ASKO mice showed no change, revealing a blunted
b3-adrenergic response (Figure 2H). Accordingly, we found
that FA oxidation was blunted in both white and brown adipo-
cytes from desnutrin-ASKO mice (Figure 2I). Despite adiposity
and impaired BAT function, desnutrin-ASKO mice have
improved hepatic insulin sensitivity with lower DAG levels
(Figures S2A–S2I).
Desnutrin Ablation Promotes the Conversion of BAT
to a WAT-like Tissue
Transmission electron microscopy showed that while BAT from
flox/flox mice had numerous small lipid droplets, BAT from des-
nutrin-ASKOmice contained larger, but fewer lipid droplets (Fig-
ure 3A). We also observed fewer mitochondria in BAT from des-
nutrin-ASKO mice, and the majority of mitochondria were
composed of randomly oriented cristae, characteristic of WAT,
compared to the classic laminar cristae in BAT from flox/flox
mice (Figure 3B). However, morphology of BAT was not altered
in desnutrin-ASKO mice at either E17 or E21, suggesting that
the conversion of BAT to a WAT-like phenotype in desnutrin-
ASKO mice is likely due to the metabolic consequence of
decreased desnutrin-catalyzed lipolysis in adults rather than
a developmental defect (Figure S3). Furthermore, BAT from des-
nutrin-ASKO mice showed no changes in the expression of
genes that may be critical for BAT development, including
Pref-1, C/EBPa, C/EBPd, PPARg, and PRDM16 (Figure 3C). In
contrast, expression of genes involved in thermogenesis and
mitochondrial and peroxisomal FA oxidation, such as ATP5B,
COXIV, CPT1b, PHYH, CIDEA, and PPARa, were all decreased
Figure 1. Increased Adiposity in Desnutrin-ASKO Mice
(A) Generation of adipose-specific desnutrin knockout mice.
(B) Western blotting of lysates (40 mg) from WAT, BAT, heart, and liver using a desnutrin antibody (upper) and RT-qPCR for desnutrin expression in the
macrophage and BAT (lower).
(C) Male mice on a HFD at 16 weeks of age.
(D) Gonadal, renal, and BAT fat depots (upper, middle, and lower).
(E) Gonadal (Gon), Inguinal (Ing), renal (Ren), and brown adipose tissue (BAT) fat pad weights and food intake (inset) (n = 7).
(F) Liver, kidney, heart, and lung weights (n = 7).
(G) Hematoxylin and eosin-stained paraffin-embedded sections of gonadal WAT (left) and BAT (right) and quantification of cell size. Scale bar (WAT) = 20 mm,
scale bar (BAT) = 40 mm. Data are expressed as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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Desnutrin/ATGL Ablation in Adipose Tissue and AMPKby 35%–50% (Figure 3D, left). UCP-1 expression was markedly
decreased at both the mRNA and protein level (Figures 3D, left,
and 3F). RIP140 and CtBP1, transcriptional corepressors that
may suppress oxidative and thermogenic genes in adipose
tissue, were upregulated in BAT of desnutrin-ASKO mice byC2.8- and 3.5-fold, respectively (Figure 3D, middle) (Fru¨hbeck
et al., 2009). In addition, expression of WAT-enriched genes
such as Igfbp3, DPT, Hoxc9, and Tcf21 were strongly induced
in BAT of desnutrin-ASKO mice (Figure 3D, right). Consistent
with our findings in BAT, expression of UCP-1, CPT1b, andell Metabolism 13, 739–748, June 8, 2011 ª2011 Elsevier Inc. 741
Figure 2. Decreased Lipolysis in Desnutrin-ASKO Mice Results in Impaired Thermogenesis and Energy Expenditure
(A) Glycerol (left) and FA (right) release from explants of gonadal WAT (n = 6).
(B) FA release from isolated white adipocytes.
(C) FA release from explants of BAT (n = 3).
(D) Percent TAG turnover (left) and percent de novo palmitate turnover (right) in gonadal WAT and BAT.
(E) Body temperatures of mice exposed to the cold (4C) in the fasted state.
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Desnutrin/ATGL Ablation in Adipose Tissue and AMPKPPARa was also decreased in WAT of desnutrin-ASKO mice
(Figure 3E).
Lower FA levels within adipocytes due to blunted desnutrin-
catalyzed lipolysis in desnutrin-ASKO mice may affect the
activity of PPARs to control the expression of many oxidative
and thermogenic genes. PPARa, in addition to PPARg, have
been shown to activate the UCP-1 promoter (Barbera et al.,
2001). By RT-qPCR, we found that, among the three PPAR
members, only PPARa is expressed at a much higher level in
BAT compared to WAT (Figure 3G). We detected less PPARa
bound to the 2.5 kb enhancer region of the UCP-1 promoter in
desnutrin-ASKO mice compared to flox/flox mice (Figure 3H).
We also observed lower binding of RIP140 to the UCP-1
promoter in BAT of desnutrin-ASKO mice, despite significantly
higher expression levels. Although RIP140 has been reported
to play a role in suppressing a BAT phenotype, our results
suggest that impaired binding of PPARa may have precluded
binding of this corepressor in our desnutrin-ASKO mice. Similar
to our findings in BAT of desnutrin-ASKOmice, we found that the
expression of UCP-1, CIDEA, COXIV, and CPT1b were all
decreased in BAT of PPARa null mice (Figure 3I). Furthermore,
PPARa null mice were also unable to maintain body temperature
during cold exposure (Figure 3J). Additionally, adipocyte FA
oxidation was also blunted in these mice (Figure 3K). Our finding
that PPARa null mice phenocopy desnutrin-ASKO in regards to
thermogenesis suggests that desnutrin-catalyzed lipolysis may
activate PPARa to promote thermogenesis.
AMPK Phosphorylates Desnutrin to Increase
Its TAG Hydrolase Activity
Cold exposure and b-agonist treatment induce the thermogenic
capacity of BAT, which is mediated primarily through PKA
signaling. However, desnutrin does not appear to be phosphor-
ylated by PKA (Zimmermann et al., 2004). In C. elegans, desnu-
trin was reported to be phosphorylated by AMPK to inhibit its
lipase activity to conserve energy during dauer (Narbonne and
Roy, 2009). However, the AMPK phosphorylation site identified
in C. elegans is not conserved in mammalian desnutrin. Mass
spectrometry analysis detected two phosphorylated serine resi-
dues in murine desnutrin (S406 and S430) (Kim et al., 2006). We
speculated that, being a perfect AMPK consensus site, S406
might be an AMPK phosphorylation site (Figure 4A). We thus
attempted to in vitro phosphorylate desnutrin, which was immu-
noprecipitated from HEK293 cells transfected with desnutrin
expression vector, using purified AMPK and [g-32P]ATP. Indeed,
we detected phosphorylation of desnutrin by AMPK in vitro (Fig-
ure 4B). To identify the specific site(s) of desnutrin that AMPK
phosphorylates, we generated nonphosphorylatable alanine
mutant forms of desnutrin at the two putative phosphorylation
sites (S406A and S430A) and used them for in vitro phosphory-
lation. While WT and the S430A desnutrin mutant were phos-
phorylated by AMPK, the S406A mutant was not, indicating
S406 of desnutrin to be a unique and bona fide AMPK phosphor-
ylation site (Figures 4B and 4C). Interestingly, we also found the(F) In vitro TAG hydrolase activity in BAT of mice upon cold exposure and weste
(G) Oxygen consumption rate (VO2) measured through indirect calorimetry.
(H) VO2 after intraperitoneal injection of CL316243.
(I) FA oxidation in white (left) and brown (right) adipocytes (n = 4). Data are expre
Camino acid sequence at S406 of desnutrin to be a perfect 14-3-3
binding motif. A specific 14-3-3 phospho-binding peptide
antibody detected WT desnutrin but not the S406 mutant (Fig-
ure 4B). Furthermore, we could detect a direct interaction
between desnutrin and 14-3-3 by pull-down assay using GST-
14-3-3 and in vitro translated product of desnutrin (Figure 4D),
but not when desnutrin product was first treated with alkaline
phosphatase, demonstrating its dependence on desnutrin
phosphorylation.
Next, we transfected HEK293 cells with desnutrin and treated
themwith the cell-permeable AMPK-activator, AICAR, as well as
the AMPK inhibitor compound C.We found that phosphorylation
of desnutrin at S406 was increased in cultured cells by AICAR
treatment, but suppressed by compound C, paralleling phos-
phorylation of AMPK and ACC (Figure 4E). We next measured
the TAG hydrolase activity of WT desnutrin, the nonphosphory-
latable S406A mutant, as well as the phosphorylation mimicking
aspartate mutant (S406D). We found that TAG hydrolase activity
of S406A and S406D mutant was decreased compared to WT
desnutrin (Figure 4F). Moreover, by GST pull-down assay we
found that mutation of S406 of desnutrin to either alanine or
aspartate blocked interaction with 14-3-3, correlating with
decreased lipase activity in these mutants (Figure 4G). Further-
more, immunoprecipitation of HEK293 cells cotransfected with
WT desnutrin, S406A mutant, S406D mutant, or GFP control
and Myc-tagged 14-3-3 showed an interaction of 14-3-3 with
WT desnutrin, but not with the S406A or S406D mutants (Fig-
ure 4H). In this regard, previous studies have shown that serine
to aspartate substitution, thought to mimic phosphorylated
serine, are inactive in some cases for 14-3-3 proteins (Kaeser
et al., 2008).
To determine the role of AMPK specifically on desnutrin-cata-
lyzed lipolysis, we transfected WT desnutrin or S406A mutant
into oleate-loaded HEK293 cells, which express a very low level
of endogenous HSL. The AICAR treatment increased lipolysis by
1.8-fold in cells transfected withWT desnutrin, but failed to do so
in S406A mutant transfected cells, indicating that AMPK-activa-
tion increases lipolysis via phosphorylation of S406 of desnutrin
(Figure 4I).
Phosphorylation of Desnutrin by AMPK Increases
Desnutrin-Catalyzed Lipolysis in Cultured Adipocytes
and in an In Vivo Context in Mice
The effect of AMPK in regulating lipolysis in adipose tissue has
been controversial (Daval et al., 2005; Yin et al., 2003). Since
adipocytes express high levels of endogenous HSL, it is difficult
to dissociate the effect of desnutrin on lipolysis from that of HSL
(Figure S4E). To overcome this obstacle, we utilized adenovirus
for high-level overexpression of WT desnutrin, S406A mutant
desnutrin, or GFP control in differentiated 3T3-L1DCAR adipo-
cytes stably expressing the gene-encoding coxsackie and
adenovirus receptor (Orlicky et al., 2001). We found that over-
night pretreatment with AICAR increased lipolysis by 50% in
control adipocytes. Desnutrin levels were unchanged duringrn blotting for desnutrin (inset).
ssed as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
ell Metabolism 13, 739–748, June 8, 2011 ª2011 Elsevier Inc. 743
Figure 3. Desnutrin Ablation Converts of BAT to a WAT-like Phenotype
(A and B) Transmission electron microscopy of BAT showing the lipid droplet, scale bar = 2 mm (A), or focused on mitochondria, scale bar = 0.2 mm (B).
(C) RT-qPCR of BAT (n = 5–10).
(D) RT-qPCR of BAT (n = 5–10) (ND = not detected).
(E) RT-qPCR of WAT (n = 5–10).
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response to AICAR treatment, we found that only WT desnutrin,
and not the S406Amutant, showed an increase in lipolysis above
control levels, clearly demonstrating that AMPK phosphorylation
of desnutrin at S406 increases lipolysis in adipocytes (Figure 4J).
To test the effect of AMPK on lipolysis in vivo, we next admin-
istered AICAR intraperitoneally to flox/flox and desnutrin-ASKO
mice. Five hours after injection, we detected that AICAR
increased serum FA levels in control, flox/flox mice but not in
desnutrin-ASKO mice, indicating that the AMPK-mediated
increase in lipolysis is desnutrin dependent (Figure 4K). We
also examined effects of chronic AICAR treatment. After 3 weeks
of AICAR treatment, expression of genes involved in FA oxida-
tion, PPARa and CPT1b, was induced in adipose tissue of flox/
flox mice, but not in desnutrin-ASKO mice (Figure 4L).
To further address the biological significance of S406 phos-
phorylation of desnutrin, we performed tail vein injection of
adenovirus of WT desnutrin, S406A mutant, and control GFP
into mice. While TAG hydrolase activity was increased in the
livers of WT desnutrin-infected mice compared to control
virus-infected mice, the activity remained low in the livers of
S406A mutant-injected mice (Figure 4M). Hepatic TAG levels
were drastically decreased in WT desnutrin-infected mice as
compared to control-GFP adenovirus-injected mice, as deter-
mined by TAG content and by sectioning and staining with oil
red O (Figure 4N). In contrast, hepatic TAG levels were only
marginally decreased in the livers of S406A mutant-infected
mice (Figure 4N).
DISCUSSION
Impaired BAT function in our desnutrin-ASKOmice can be attrib-
uted to (1) decreased expression of oxidative and thermogenic
genes and (2) severely blunted lipolysis that lowers FAs, prevent-
ing UCP-1 activation and decreasing FA oxidation. Notably, the
conversion of BAT to a WAT-like tissue observed in desnutrin-
ASKO mice does not appear to be due to decreased lipolysis in
general, since opposing changes in BAT were observed in other
mouse models with altered lipolysis. HSL null mice had an
enhancement of BAT-like features in WAT, while mice overex-
pressing perilipin in adipose tissue with blunted lipolysis ex-
hibited increased expression of oxidative genes in BAT (Miyoshi
et al., 2010; Strom et al., 2008). Furthermore, unlike HSL null
mice, desnutrin-ASKO mice exhibit a phenotype similar to
b-adrenergic receptor-ablated mice (Bachman et al., 2002;
Strom et al., 2008). These findings establish that desnutrin-
catalyzed lipolysis is a major determinant of thermogenesis,
required for a BAT phenotype, and that different lipases may
regulate distinct metabolic pathways. In this regard, our previous
studies on transgenic mice overexpressing desnutrin in adipose
tissue also showed increased expression of UCP-1 and other
oxidative genes inWATwith high FA oxidation within adipocytes.(F) Western blotting (upper) and immunostaining (lower) for UCP-1 in BAT.
(G) RT-qPCR for PPARa, d, and g in WAT and BAT of WT mice (n = 3–5).
(H) Chromatin immunoprecipitation (ChIP) using a PPARa, RIP140, or control GA
(I) RT-qPCR in BAT of PPARa null mice (n = 4–5).
(J) Body temperature of WT and PPARa null mice exposed to 4C in the fasted s
(K) FA oxidation in white adipocytes from WT and PPARa null mice. Data are ex
CRecently, it has been reported that WAT and BAT are inter-
mingled in a single fat depot of rodents and may be capable of
so called ‘‘transdifferentiation’’ or ‘‘browning,’’ as observed by
increased BAT-like properties during cold exposure (Barbatelli
et al., 2010; Frontini and Cinti, 2010). While de novo differentia-
tion of precursor cells could occur, this is unlikely, since we did
not detect any differences in PRDM16 expression in BAT from
desnutrin-ASKO mice, nor did we detect any changes in the
morphology of BAT during embryonic development (Frontini
and Cinti, 2010). While themechanism underlying ‘‘transdifferen-
tiation’’ is not known, desnutrin-catalyzed lipolysis may play an
important role in the plasticity of adipocytes, conceivably by
providing ligands for binding/activation of PPARa. Lower PPARa
binding to theUCP-1 promoter in BAT of desnutrin-ASKOmice is
consistent with other reports showing reduced PPARa binding to
its target genes upon decreased ligand availability (Mandard
et al., 2004; van der Meer et al., 2010). Although PPARg can
bind to the same enhancer region of the UCP-1 promoter
(Barbera et al., 2001), it has been proposed that PPARg may
play a more important role during BAT development, while
PPARa may be critical for function of mature BAT (Villarroya
et al., 2007). Accordingly, we found that only PPARa is ex-
pressed at a much higher level in BAT compared to WAT. We
also found that PPARa null mice have decreased expression of
UCP-1 and other oxidative and thermogenic genes, with
impaired thermogenesis. This is in contrast with reported PPARg
null mice having normal UCP-1 levels in BAT with functional
thermogenesis (He et al., 2003).
Upon cold exposure or b-adrenergic stimulation, AMPK
activity in BAT has been reported to increase, suggesting its
role in regulating thermogenesis through activation of AMPK
by PKA (Mulligan et al., 2007). However, this is controversial,
with some reports showing activation of AMPK by PKA and
others showing inhibition (Djouder et al., 2010; Omar et al.,
2009). Furthermore, the role of AMPK in the regulation of lipolysis
has also been controversial (Daval et al., 2005; Yin et al., 2003).
Here, we found that AMPK phosphorylates S406 of desnutrin to
increase its activity and promote lipolysis. Our results predict
that, during cold exposure, AMPKmay phosphorylate desnutrin,
stimulating TAG hydrolase activity and thermogenesis. Our
findings that cold exposure induces TAG hydrolase activity in
BAT without changing desnutrin expression and that this
cold-induced increase in TAG hydrolase activity was blunted in
desnutrin-ASKO mice are consistent with the notion that desnu-
trin is regulated by posttranslational modification in BAT during
cold exposure. Our findings are also in line with the well-estab-
lished role of AMPK as a cellular energy sensor. If AMPK
increases FA oxidation, it is logical that FA substrates must be
increased. In support of this idea, our current studies as well
as previous studies on transgenic mice overexpressing desnu-
trin in adipose tissue show that desnutrin-catalyzed lipolysis
promotes FA oxidation. It is conceivable that AMPK mayPDH antibody for binding to the UCP-1 promoter.
tate (n = 4).
pressed as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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dian et al., 2009b). Our observation that chronic AICAR adminis-
tration induced expression of PPARa and CPT1b in control mice
but not in desnutrin-ASKO mice further links AMPK-desnutrin-
PPARa to increased FA oxidation and UCP-1 induction for
thermogenesis. In this regard, we previously reported that
mice lacking AMPKa2 are obese with adipocyte hypertrophy
(Villena et al., 2004b). Since even a modest amount of BAT
may account for a significant portion of daily energy expenditure
(Fru¨hbeck et al., 2009), strategies designed at targeting AMPK
phosphorylation/activation of desnutrin might offer promising
therapeutic approaches for obesity and related disorders.
EXPERIMENTAL PROCEDURES
Generation of Desnutrin-ASKO Mice and Mouse Maintenance
All studies received approval from the University of California at Berkeley
Animal Care and Use Committee. Generation and maintenance of various
mouse strains are described in detail in the Supplemental Experimental
Procedures.
Antibody Generation, Immunoblotting, and Immunoprecipitation
Desnutrin antibody was raised in rabbits against the C-terminal amino acids of
desnutrin (TAADPATPQDPPGLPPC). Use of various antibodies in immuno-
blotting and immunoprecipitation is described in detail in the Supplemental
Experimental Procedures.
Chromatin Immunoprecipitation
BAT isolation, fixation, and ChIP are described in detail in the Supplemental
Experimental Procedures.
RNA Extraction and Real-Time RT-PCR
Total RNA was prepared using TRIzol Reagent (Invitrogen), and cDNA was
synthesized from 2.5 mg of RNA by Superscript II reverse transcriptase (Invitro-
gen). Gene expression was determined by RT-qPCR performed with an ABI
PRISM7700 sequence fast detection system (Applied Biosystems) and was
quantified by measuring the threshold cycle normalized to GAPDH, then ex-
pressed relative to flox/flox controls. Custom primers and probes are given
in the Supplemental Information.
In Vitro Phosphorylation and TAG Hydrolase Activity Assays
In vitro phosphorylation and TAG hydrolase activity assays were performed as
described in the Supplemental Experimental Procedures.Figure 4. Desnutrin Is Phosphorylated by AMPK to Increase Lipolysis
(A) AMPK consensus motif and murine desnutrin S406.
(B) Autoradiography to detect phosphorylated desnutrin after in vitro phosphory
ylation of S406 of desnutrin (middle) and HA antibody to detect total desnutrin p
(C) Autoradiography for phosphorylated desnutrin and western blot using an HA
(D) GST pull-down assay with in vitro translated desnutrin and GST-14-3-3 with
(E) Western blot for phospho-desnutrin at S406A, phospho-AMPK at Thr172, and
compound C and AICAR.
(F) TAG hydrolase assay and western blot showing desnutrin overexpression (ins
(G) GST pull-down of in vitro-translated WT or desnutrin mutants with GST-14-3
(H) Cotransfection followed by coimmunoprecipitation of 14-3-3-Myc with WT o
(I) Glycerol release from HEK293 cells transfected with WT or S406A desnutrin, t
(J) FA release from differentiated 3T3-L1DCAR adipocytes infected with WT desn
and western blot showing overexpression (inset).
(K) Serum FA levels after injection with AICAR.
(L) RT-qPCR for CPT1b and PPARa from gonadal WAT (n = 5).
(M and N) In vitro TAG hydrolase activities. TAG levels (left) and cryosectioning and
desnutrin, S406A mutant, or GFP control adenovirus. Expression levels of WT de
shown in inset. Data are expressed as means ± SEM. *p < 0.05, **p < 0.01, ***p
CGST Pull-Down Assay
Production of GST-fusion proteins by overexpression in E. coli, generation of
in vitro translation products, and GST pull-down assay are described in the
Supplemental Experimental Procedures.
Adipocyte Isolation, Size Determination, Cryosectioning, and
Transmission Electron Microscopy
Gonadal fat samples and intrascapular BAT were used for adipocyte isolation.
Cell sizemeasurement, cryosectioning, and transmission electronmicroscopy
were performed as described in the Supplemental Experimental Procedures.
Adipose Lipolysis and FA Oxidation
Lipolysis using adipose explants and isolated adipocytes and FA oxidation in
isolated adipocytes were determined as described in the Supplemental
Experimental Procedures.
Glucose and Insulin Tolerance Tests and Hyperinsulinemic-
Euglycemic Clamp
For the GTT, we intraperitoneally injected mice with D-glucose (2 mg/g body
weight) after an overnight fast and monitored tail blood glucose levels. For
ITT, mice were intraperitoneally injected with insulin (humulin, Eli Lilly)
(0.75 mU/g body weight) after a 5 hr fast. Hyperinsulinemic-euglycemic clamp
procedures are described in the Supplemental Experimental Procedures.
2H2O Labeling and GCMS Analysis of TAG-Glycerol and TAG-FA and
Calculation of All-Source TAG Turnover and Palmitate Turnover
The detailed methods and calculation are described in the Supplemental
Experimental Procedures.
Indirect Calorimetry and Body Temperature
Oxygen consumption (VO2) was measured using the Comprehensive Labora-
tory Animal Monitoring System (CLAMS; Columbus, OH). Data were normal-
ized to body weights. Body temperatures were assessed in 25-week-old
male mice using a RET-3 rectal probe for mice (Physitemp). CL316243 (Sigma)
was intraperitoneally injected into mice at 1 mg/kg body weight.
TAG and DAG Extraction and Metabolite Measurements
Extractions andmetabolite measurements were performed as described in the
Supplemental Experimental Procedures.
Statistical Analyses
Data are expressed as means ± SEM. Statistically significant differences
between two groups were assessed by Student’s t test.lation and western blot using a phospho-14-3-3 antibody to detect phosphor-
rotein (lower).
antibody for total desnutrin.
or without alkaline phosphatase treatment (APase).
phospho-ACC at Ser79 in WT desnutrin-transfected HEK293 cells treated with
et).
-3.
r desnutrin mutant.
reated with or without AICAR.
utrin, S406A mutant, or GFP control adenovirus after pretreatment with AICAR,
staining with oil red O (right) of the livers of HFD-fedWTmice infected withWT
snutrin and S406A mutant upon adenovirus injection in liver by RT-qPCR are
< 0.001.
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